Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants
- PMID: 25460554
- DOI: 10.1016/j.cgh.2014.11.007
Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants
Abstract
Background & aims: Treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin is associated with increased risk of upper gastrointestinal bleeding. There is little evidence on the risk of lower gastrointestinal bleeding with NSAIDs, antiplatelet agents (APAs), or anticoagulants. We aimed to quantify the relative risk (RR) of upper and lower gastrointestinal bleeding associated with use of NSAIDs, APAs, or anticoagulants.
Methods: We performed a case-control study that used data collected from consecutive patients hospitalized for gastrointestinal bleeding (563 upper, mean age, 63.6 ± 16.7 years and 415 lower, mean age, 70.8 ± 13.8 years), confirmed by endoscopy or other diagnostic procedures. Unhospitalized patients were used as controls (n = 1008) and matched for age, hospital, and month of admission. Drug use was considered current when taken within 7 days or less before hospitalization. RRs and 95% confidence intervals (CIs) were estimated by unconditional logistic regression analysis.
Results: Use of anticoagulants, low-dose aspirin, and other drugs (non-aspirin-APA, 82.3% thienopiridines) was associated with upper and lower gastrointestinal bleeding; the risk was 2-fold higher for anticoagulants (RR, 4.2; 95% CI, 2.9-6.2) than for low-dose aspirin (RR, 2.1; 95% CI, 1.4-3.3) or other non-aspirin-APA drugs (RR, 2.0; 95% CI, 1.6-2.6). NSAID use was also associated with increased risk of gastrointestinal bleeding and greater for upper (RR, 2.6; 95% CI, 2.0-3.5) than lower gastrointestinal bleeding (RR, 1.4; 95% CI, 1.0-1.9). Use of proton pump inhibitors was associated with reduced risk of upper, but not lower, gastrointestinal bleeding.
Conclusions: Anticoagulants, low-dose aspirin, NSAIDs, and other non-aspirin-APA drugs are associated with increased risk of upper and lower gastrointestinal bleeding. Use of anticoagulants appears to be the strongest risk factor for gastrointestinal bleeding.
Keywords: Colon; Complication; Intestine; Peptic Ulcer; Side Effect; Small Bowel; Stomach.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.
Comment in
-
Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-Inflammatory Drugs, Antiplatelet Agents, or Anticoagulants.Clin Gastroenterol Hepatol. 2015 Nov;13(11):2023-4. doi: 10.1016/j.cgh.2015.05.025. Epub 2015 May 28. Clin Gastroenterol Hepatol. 2015. PMID: 26027546 No abstract available.
-
Reply: To PMID 25460554.Clin Gastroenterol Hepatol. 2015 Nov;13(11):2024-5. doi: 10.1016/j.cgh.2015.07.022. Epub 2015 Jul 18. Clin Gastroenterol Hepatol. 2015. PMID: 26196444 No abstract available.
Similar articles
-
Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.Am J Gastroenterol. 2007 Mar;102(3):507-15. doi: 10.1111/j.1572-0241.2006.01062.x. Am J Gastroenterol. 2007. PMID: 17338735
-
Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy.J Gastroenterol Hepatol. 2014 Oct;29(10):1786-93. doi: 10.1111/jgh.12595. J Gastroenterol Hepatol. 2014. PMID: 24720424
-
Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study.PLoS One. 2016 Mar 15;11(3):e0151332. doi: 10.1371/journal.pone.0151332. eCollection 2016. PLoS One. 2016. PMID: 26978517 Free PMC article.
-
Nonsteroidal Antiinflammatory Drugs, Anticoagulation, and Upper Gastrointestinal Bleeding.Clin Geriatr Med. 2021 Feb;37(1):31-42. doi: 10.1016/j.cger.2020.08.004. Epub 2020 Nov 2. Clin Geriatr Med. 2021. PMID: 33213773 Review.
-
Strategies to reduce the GI risks of antiplatelet therapy.Rev Cardiovasc Med. 2005;6 Suppl 4:S23-31. Rev Cardiovasc Med. 2005. PMID: 17710073 Review.
Cited by
-
Initial management for acute lower gastrointestinal bleeding.World J Gastroenterol. 2019 Jan 7;25(1):69-84. doi: 10.3748/wjg.v25.i1.69. World J Gastroenterol. 2019. PMID: 30643359 Free PMC article. Review.
-
Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view.World J Cardiol. 2023 Aug 26;15(8):375-394. doi: 10.4330/wjc.v15.i8.375. World J Cardiol. 2023. PMID: 37771340 Free PMC article. Review.
-
[Mortality Risk Factors for Inpatients with Ischemic Heart Disease Complicated with Gastrointestinal Bleeding].Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 Nov;52(6):1034-1040. doi: 10.12182/20211160108. Sichuan Da Xue Xue Bao Yi Xue Ban. 2021. PMID: 34841774 Free PMC article. Chinese.
-
Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation.PLoS One. 2021 Nov 29;16(11):e0260585. doi: 10.1371/journal.pone.0260585. eCollection 2021. PLoS One. 2021. PMID: 34843582 Free PMC article.
-
[Upper abdominal pain: a frequent and multifaceted leading symptom in primary care internal medicine].Internist (Berl). 2021 Jan;62(1):3-16. doi: 10.1007/s00108-020-00917-7. Epub 2020 Dec 17. Internist (Berl). 2021. PMID: 33331949 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical